<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179"><gtr:id>FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179</gtr:id><gtr:name>University of Florida</gtr:name><gtr:address><gtr:line1>University of Florida</gtr:line1><gtr:line4>Gainesville</gtr:line4><gtr:line5>Florida FL 32611</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:department>Medicine Dentistry and Biomedical Sci</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179"><gtr:id>FEDC2C7D-5094-4EC0-BD8F-115B7BCB6179</gtr:id><gtr:name>University of Florida</gtr:name><gtr:address><gtr:line1>University of Florida</gtr:line1><gtr:line4>Gainesville</gtr:line4><gtr:line5>Florida FL 32611</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D90C8E3D-22CD-429D-8B85-0266CF97A459"><gtr:id>D90C8E3D-22CD-429D-8B85-0266CF97A459</gtr:id><gtr:firstName>Jenny</gtr:firstName><gtr:surname>Ames</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/99BEA871-19EA-4BE4-AA9B-8E90415A58D7"><gtr:id>99BEA871-19EA-4BE4-AA9B-8E90415A58D7</gtr:id><gtr:firstName>Usha</gtr:firstName><gtr:surname>Chakravarthy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B304CB3D-8744-4B16-8A3F-4A04B4E8290F"><gtr:id>B304CB3D-8744-4B16-8A3F-4A04B4E8290F</gtr:id><gtr:firstName>John J.</gtr:firstName><gtr:surname>McGarvey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/915D733E-5C8C-4CE2-9036-0E787736F4C7"><gtr:id>915D733E-5C8C-4CE2-9036-0E787736F4C7</gtr:id><gtr:firstName>Alan</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Stitt</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A3B9B85D-1FE7-4413-9BD7-9E7D5ACCCCCC"><gtr:id>A3B9B85D-1FE7-4413-9BD7-9E7D5ACCCCCC</gtr:id><gtr:firstName>Mike</gtr:firstName><gtr:surname>Boulton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600053"><gtr:id>DE72054B-3FD4-4A14-983F-75E1DB31F0C7</gtr:id><gtr:title>Raman spectroscopic evaluation of protein modification: a new, non-invasive diagnostic tool for age-related eye disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600053</gtr:grantReference><gtr:abstractText>Rapid, non-invasive evaluation of robust markers of disease progression in the eyes of aging patients would provide a novel and exciting basis for recognising risk of visual loss and perhaps also link to other age-related diseases such as cataract formation and glaucoma. The proposed project builds on knowledge from the scientific literature, strong international collaboration and key preliminary findings. It will seek to establish a firm basis for using confocal Raman microscopy and spectroscopic evaluation of patients to study chemical modifications called advanced glycation endproducts (AGEs) in the eye. The approach is multidisciplinary and represents collaboration between vision scientists, physical chemists, ophthalmologists and optometrists. Together, this unusual team can offer a unique perspective on a pressing research problem. The project will ascertain age-related risk in a patient-based evaluation of AGE-mediated Raman spectra in ocular tissues. With appropriate identification, quantification and validation of AGE moieties in the eye and their correlation with age-mediated pathophysiology, Raman spectra could ultimately form an important, non-invasive diagnostic tool for AMD and other age-associated ocular defects.</gtr:abstractText><gtr:technicalSummary>Age-related macular degeneration (AMD) remains the leading cause of irreversible blindness in older people in the UK and clinical intervention options for AMD are severely limited. We still know remarkably little about this important retinal disease and although age remains the main risk factor, the associated progression from sub-clinical age-related maculopathy (ARM) is ambiguous. There is no firm basis for early diagnosis of the ~2.2 million people in the UK who are affected by AMD. 
Rapid, non-invasive evaluation of robust markers of disease progression in the eyes of ageing patients would provide a novel and exciting basis for recognizing age-related risk from potentially blinding conditions. The proposed project is truly ?translational? and builds on knowledge from the scientific literature, strong international collaboration and key preliminary findings. It will seek to establish a firm basis for using confocal Raman microscopy of post-mortem clinical material and parallel spectroscopic evaluation of patients to study chemical modifications called advanced glycation endproducts (AGEs) in the eye. The approach is multidisciplinary and, since it brings together an uncommon collaboration between ophthalmic biologists physical chemists and optometrists, offers a unique perspective on a pressing research problem. The project will ascertain age-related risk associated with these harmful adducts in appropriate in vitro experiments, ex vivo studies and complementary evaluation of relevant clinical specimens. In parallel with this research, we propose to conduct a patient-based evaluation of AGE-mediated Raman spectra in ocular tissues. With appropriate identification, quantification and validation of AGE moieties in the eye and their correlation with pathophysiology, Raman spectra could ultimately form an important diagnostic tool for age-related ocular defects in general and progression to AMD in particular.</gtr:technicalSummary><gtr:fund><gtr:end>2010-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>433128</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Florida</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>College of Medicine</gtr:department><gtr:description>Use of human ocular specimens</gtr:description><gtr:id>7BA5FDDC-8610-472A-94D5-8E16B51BA39E</gtr:id><gtr:impact>Glenn JV, Mahaffy H, Wu K, Smith G, Nagai R, Simpson DA, Boulton ME, Stitt AW. Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction. Invest Ophthalmol Vis Sci. 2009 Jan;50(1):441-51. 

Beattie JR, Pawlak AM, Boulton ME, Zhang J, Monnier VM, McGarvey JJ, Stitt AW. Multiplex analysis of age-related protein and lipid modifications in human Bruch's membrane. FASEB J. 2010 Dec;24(12):4816-24. 

Glenn JV, Mahaffy H, Dasari S, Oliver M, Chen M, Boulton ME, Xu H, Curry WJ, Stitt AW. Proteomic profiling of human retinal pigment epithelium exposed to an advanced glycation-modified substrate. Graefes Arch Clin Exp Ophthalmol. 2011 Nov 13. [Epub ahead of print]</gtr:impact><gtr:outcomeId>gCsjzCm8y2p-1</gtr:outcomeId><gtr:piContribution>Prof Mike Boulton provided expertise and access to clinical samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Diego (UCSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pathology</gtr:department><gtr:description>Sharing of reagents/resources</gtr:description><gtr:id>D88C3B8A-0DF6-40E2-8162-FA73B83BE874</gtr:id><gtr:impact>FASEB J. 2010 Dec;24(12):4816-24.</gtr:impact><gtr:outcomeId>WaKk5mR7Sqj-1</gtr:outcomeId><gtr:partnerContribution>Sharing of AGE moieties for our research</gtr:partnerContribution><gtr:piContribution>The collaboration was based on chemical synthesis expertise from the Case Western Partner (Prof Vicent Monnier)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Unique software to analyse complex Raman spectra in biological tissue.</gtr:description><gtr:id>0E30C88E-04E4-447D-9F59-C40E4D8B4851</gtr:id><gtr:impact>Combined with the new spectroscope, this software allows rapid analysis of Raman data</gtr:impact><gtr:outcomeId>F1CF51EB753</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Raman analysis software</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6AF86D2F-4707-44A4-9544-FD7FD0543FE5</gtr:id><gtr:title>Identifying the spatial distribution of vitamin E, pulmonary surfactant and membrane lipids in cells and tissue by confocal Raman microscopy.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da2d994f79978643a7dd149316390b68"><gtr:id>da2d994f79978643a7dd149316390b68</gtr:id><gtr:otherNames>Beattie JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_14194_14_19763493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80933BEC-2145-4000-853C-6C8151C95CA8</gtr:id><gtr:title>Effect of signal intensity normalization on the multivariate analysis of spectral data in complex 'real-world' datasets</gtr:title><gtr:parentPublicationTitle>Journal of Raman Spectroscopy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9585f56d5f92c7ba4bad859b5f14466d"><gtr:id>9585f56d5f92c7ba4bad859b5f14466d</gtr:id><gtr:otherNames>Beattie J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>F0ED51F1449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4A9F571-E413-4A28-B52C-E919AE1C4104</gtr:id><gtr:title>Advanced glycation end products and diabetic retinopathy.</gtr:title><gtr:parentPublicationTitle>Amino acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ca610f8d9b7eaab074c7f69ca304838"><gtr:id>0ca610f8d9b7eaab074c7f69ca304838</gtr:id><gtr:otherNames>Milne R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0939-4451</gtr:issn><gtr:outcomeId>541b034a4cf251.09573297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DD3FE3F-54E2-41B8-85BB-9DACD38D4450</gtr:id><gtr:title>Sclera as a surrogate marker for determining AGE-modifications in Bruch's membrane using a Raman spectroscopy-based index of aging.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da2d994f79978643a7dd149316390b68"><gtr:id>da2d994f79978643a7dd149316390b68</gtr:id><gtr:otherNames>Beattie JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>MRJuJCcSh2M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECD3CC68-1B73-4C3D-8DE0-C5B9612C5DE6</gtr:id><gtr:title>Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/691212164be3115b17e4f978006e5a9f"><gtr:id>691212164be3115b17e4f978006e5a9f</gtr:id><gtr:otherNames>Berner AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_14194_24_22143324</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>840F6A35-C6CC-40AD-9C37-5416F54B0B7E</gtr:id><gtr:title>AGEs and diabetic retinopathy.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02ea3d2e7d3b8dbd663c71414cfa5675"><gtr:id>02ea3d2e7d3b8dbd663c71414cfa5675</gtr:id><gtr:otherNames>Stitt AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>EhgWtXLQehW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4CE57EF-3741-43E7-A4AF-EA6E661CDA4D</gtr:id><gtr:title>Vascular stem cells and ischaemic retinopathies.</gtr:title><gtr:parentPublicationTitle>Progress in retinal and eye research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02ea3d2e7d3b8dbd663c71414cfa5675"><gtr:id>02ea3d2e7d3b8dbd663c71414cfa5675</gtr:id><gtr:otherNames>Stitt AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1350-9462</gtr:issn><gtr:outcomeId>SNmTYweQ4Na</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BF64A99-5E87-4003-AD4A-A9C87299CD2F</gtr:id><gtr:title>Multiplex analysis of age-related protein and lipid modifications in human Bruch's membrane.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da2d994f79978643a7dd149316390b68"><gtr:id>da2d994f79978643a7dd149316390b68</gtr:id><gtr:otherNames>Beattie JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>pm_14194_24_20686107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>136B8B09-01AD-4F18-9B48-5B542044F3DD</gtr:id><gtr:title>Estimation of signal backgrounds on multivariate loadings improves model generation in face of complex variation in backgrounds and constituents</gtr:title><gtr:parentPublicationTitle>Journal of Raman Spectroscopy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9585f56d5f92c7ba4bad859b5f14466d"><gtr:id>9585f56d5f92c7ba4bad859b5f14466d</gtr:id><gtr:otherNames>Beattie J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_55f983983cf11648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FA23B01-8DAE-4BFC-BDC1-D9AEA25932EE</gtr:id><gtr:title>M&amp;uuml;ller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90ad71c24867605973a96bc799aec35b"><gtr:id>90ad71c24867605973a96bc799aec35b</gtr:id><gtr:otherNames>Curtis TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>baqx6xA2hD2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>759D645F-F0EF-4722-8569-D459208AB9CD</gtr:id><gtr:title>Advanced glycation as a basis for understanding retinal aging and noninvasive risk prediction.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfc0f84a8e7593d4348cbb0a7d298b5f"><gtr:id>dfc0f84a8e7593d4348cbb0a7d298b5f</gtr:id><gtr:otherNames>Pawlak AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>D624DF48B50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF7521EE-13CA-4BBE-975E-FB4722276A91</gtr:id><gtr:title>Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8.</gtr:title><gtr:parentPublicationTitle>Molecular medicine (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28ce4d73e652be683a7f5e29a0338e42"><gtr:id>28ce4d73e652be683a7f5e29a0338e42</gtr:id><gtr:otherNames>Medina RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1076-1551</gtr:issn><gtr:outcomeId>YoASCgSqTQa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B09804C-896B-40C1-BEE0-32EEDF596B19</gtr:id><gtr:title>Optimising reproducibility in low quality signals without smoothing; an alternative paradigm for signal processing</gtr:title><gtr:parentPublicationTitle>Journal of Raman Spectroscopy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9585f56d5f92c7ba4bad859b5f14466d"><gtr:id>9585f56d5f92c7ba4bad859b5f14466d</gtr:id><gtr:otherNames>Beattie J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>doi_55f983983ce6caa8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38CD365B-864A-481C-BC06-23CC3B42C97A</gtr:id><gtr:title>Raman spectroscopy for the detection of AGEs/ALEs.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da2d994f79978643a7dd149316390b68"><gtr:id>da2d994f79978643a7dd149316390b68</gtr:id><gtr:otherNames>Beattie JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_14194_24_23296667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>254B1578-7B5D-49F1-85E2-96808C599554</gtr:id><gtr:title>Raman spectroscopy of advanced glycation end products (AGEs), possible markers for progressive retinal dysfunction</gtr:title><gtr:parentPublicationTitle>Journal of Raman Spectroscopy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/680a5ded82e3871d331d8820358c13c2"><gtr:id>680a5ded82e3871d331d8820358c13c2</gtr:id><gtr:otherNames>Pawlak A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>830503ABB44</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70942CED-123F-448E-B03C-83510B0ECBE8</gtr:id><gtr:title>Endothelial progenitors as tools to study vascular disease.</gtr:title><gtr:parentPublicationTitle>Stem cells international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28ce4d73e652be683a7f5e29a0338e42"><gtr:id>28ce4d73e652be683a7f5e29a0338e42</gtr:id><gtr:otherNames>Medina RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>L9iVeK54hFh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48659969-B55C-4410-B03E-C6DEC0E3CED0</gtr:id><gtr:title>Evidence supporting a role for N-(3-formyl-3,4-dehydropiperidino)lysine accumulation in M&amp;uuml;ller glia dysfunction and death in diabetic retinopathy.</gtr:title><gtr:parentPublicationTitle>Molecular vision</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9afda4e63edcc323c4430b6adc36a8ec"><gtr:id>9afda4e63edcc323c4430b6adc36a8ec</gtr:id><gtr:otherNames>Yong PH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1090-0535</gtr:issn><gtr:outcomeId>FKyjRSoBGVT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5603D6A-03D4-4987-BF24-5644359BB781</gtr:id><gtr:title>Eyes open to stem cells: safety trial may pave the way for cell therapy to treat retinal disease in patients.</gtr:title><gtr:parentPublicationTitle>Stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28ce4d73e652be683a7f5e29a0338e42"><gtr:id>28ce4d73e652be683a7f5e29a0338e42</gtr:id><gtr:otherNames>Medina RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-6512</gtr:issn><gtr:outcomeId>Uru1mSB84rC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C04C297C-CA52-4DBA-A789-2116C65032E5</gtr:id><gtr:title>Profiling retinal biochemistry in the MPDZ mutant retinal dysplasia and degeneration chick: a model of human RP and LCA.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da2d994f79978643a7dd149316390b68"><gtr:id>da2d994f79978643a7dd149316390b68</gtr:id><gtr:otherNames>Beattie JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>pm_14194_24_22159006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E98E005A-BE26-4F58-937F-37F2314649C8</gtr:id><gtr:title>The role of advanced glycation end products in retinal ageing and disease.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3634e67cbd63beda4b7c688317343f0a"><gtr:id>3634e67cbd63beda4b7c688317343f0a</gtr:id><gtr:otherNames>Glenn JV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_14194_14_19409449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09824864-B129-4561-AC64-FF3CB2650913</gtr:id><gtr:title>Proteomic profiling of human retinal pigment epithelium exposed to an advanced glycation-modified substrate.</gtr:title><gtr:parentPublicationTitle>Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3634e67cbd63beda4b7c688317343f0a"><gtr:id>3634e67cbd63beda4b7c688317343f0a</gtr:id><gtr:otherNames>Glenn JV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0721-832X</gtr:issn><gtr:outcomeId>gNnh4sV52et</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A27F96E0-5135-48F1-9C43-320BEC024A64</gtr:id><gtr:title>The pathogenic role of Maillard reaction in the aging eye.</gtr:title><gtr:parentPublicationTitle>Amino acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/969051096a179b4bc4664f76bd51e8c5"><gtr:id>969051096a179b4bc4664f76bd51e8c5</gtr:id><gtr:otherNames>Nagaraj RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0939-4451</gtr:issn><gtr:outcomeId>cc54DsFomhA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0585849F-88D3-4472-A954-17982C118B22</gtr:id><gtr:title>Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3634e67cbd63beda4b7c688317343f0a"><gtr:id>3634e67cbd63beda4b7c688317343f0a</gtr:id><gtr:otherNames>Glenn JV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>0BBD6C8AB14</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600053</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A9061818-9B1E-495A-9617-7C77200827C2</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Eye</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>